Increasing R&D initiatives and strategic partnerships by leading market players for the advancement of recombinant DNA technology are projected to fuel market expansion over the forecast period. Furthermore, research organizations are initiating programmes and granting research funding for the discovery of innovative treatments, which will boost the expansion of the recombinant DNA technology market during the projected period.
High costs and bad effects connected with gene treatments, like Cytokine Release Syndrome (CRS) or Neurological Toxicities, are important problems impeding the expansion of the recombinant DNA technology industry.
According to Coherent Market Insights' analysis, the Global Recombinant DNA Technology Market is predicted to be worth US$ 145.4 billion in 2022, with a CAGR of 7.9% during the forecast period.
Leading companies in Recombinant DNA Technology Market:
1. Thermo Fisher Scientific
The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. The company was incorporated in 1956 and is based in Waltham, Massachusetts. On December 8, 2021, thermos fisher Scientific has completed its acquisition of PPD, Inc., a leading global provider of clinical research services to the biopharma and biotech industry.
2. Merk & Co.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck known as MSD outside the United States and Canada, on June 29’ 2022 announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development.
3. Pfizer Inc.
The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19. Pfizer inc. was founded in 1849 and is headquartered in New York, New York. Pfizer in collaboration with BioNTech on November 2022 Announced their Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine.
4. Sanofi
On November 2022, Sanofi along and GSK’s next generation COVID-19 booster vaccine VIdPrevtyn Beta have been approved by the European Commission and will be readily available for fall-winter COVID-19 vaccination campaigns in Europe. Sanofi operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare in in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France.
5. Biogen Inc
Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc.
6. Profacgen
Profacgen recently on November 2022, updated its in silico protein-protein interactions predictions service to meet diversified needs of its customers. The company is established in year 2004 and headquartered in Shirley, New York and U.S. Profacgen offers bacterial fermentation, stable cell lines, cell banks, stability studies, protein production, purification, and expression services.
7. Amgen
Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas.
8. Monsanto Company
Monsanto Company, formerly (1933–64) Monsanto Chemical Company and (1901–33) Monsanto Chemical Works, American corporation that was a leading producer of chemical, agricultural, and biochemical products. After being acquired by Bayer in 2018, it ceased to exist as an entity. The company was headquartered in St. Louis, Missouri, United States.
Definition- The DNA technology enables the mass manufacture of therapeutic proteins with excellent uniformity and stability.
